SP
PFE icon

Stonebrook Private’s Pfizer PFE Stock Holding History

Stonebrook Private’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$268K Buy
11,109
+847
+8% +$22.2K 0.05% 206
2026
Q1 		$288K Buy
10,262
+1,232
+14% +$32.8K 0.06% 167
2025
Q4 		$225K Buy
9,030
+1,015
+13% +$25.6K 0.05% 184
2025
Q3 		$204K Sell
8,015
-1,638
-17% -$40.4K 0.04% 201
2025
Q2 		$234K Buy
+9,653
New +$225K 0.05% 176
2024
Q4 		– Sell
-7,202
Closed -$208K – 190
2024
Q3 		$208K Buy
+7,202
New +$210K 0.06% 171
2024
Q2 		– Sell
-8,253
Closed -$229K – 212
2024
Q1 		$229K Buy
+8,253
New +$229K 0.07% 183

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Stonebrook Private's PFE Position: Q2 2026 in Review

Stonebrook Private increased its Pfizer (PFE) stake by 8.3% in Q2 2026, buying an estimated $22.2K and bringing the position to 11,109 shares worth $268K. The position accounts for 0.05% of the portfolio, ranked #206.

Stonebrook Private first reported a position in PFE in Q1 2024 and has held it in 7 quarters since. The position peaked at $288K in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Stonebrook Private held 11,109 shares of Pfizer worth $268K as of Q2 2026.
  • Stonebrook Private bought 847 Pfizer shares in Q2 2026, an estimated $22.2K.
  • Pfizer made up 0.05% of Stonebrook Private's portfolio in Q2 2026, its #206 holding.
  • Stonebrook Private first reported a position in Pfizer in Q1 2024 and has held it in 7 quarters since.
  • Stonebrook Private's Pfizer position peaked at $288K in Q1 2026.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Stonebrook Private's 13F filing for Q2 2026, filed 14 Aug 2026.